Historical Earnings Track Record
Over the last eight reported quarters, HCA has beaten consensus EPS estimates in all eight reports, producing a 100% beat rate and an average earnings surprise of 6.4%. The five-trading-day drift following those releases has averaged 1.75% and is classified as "up," meaning the post-announcement price action has tilted higher through the close of the Friday after each report.
The beats have not required massive surprises to lift the stock. In the most recent quarter, reported 2026-07-24, HCA delivered $7.59 versus the $7.56 estimate, a 0.4% beat, yet the stock rose 1.94% the next session and 5.34% over the following five trading days. That was the fourth consecutive beat, following the 2026-04-24 report ($7.15 vs $7.12, also a 0.4% surprise), which produced a 3.09% next-day gain but only a 0.15% five-day move. The pattern is not uniform: the 2026-01-27 quarter, with a much larger 7.4% surprise ($8.01 vs $7.46), saw the shares fall 2.89% the next day and 1.31% over the next five sessions. Looking back to the 2025-10-24 release, HCA produced a 20.2% surprise ($6.96 vs $5.79), a 4.66% next-day gain, and a 2.83% five-day move. The overall drift remains positive, but the cross-quarter variance shows that headline beats alone do not guarantee directional follow-through.
Options-Flow Dynamics Around 2026-10-23
The next scheduled report is 2026-10-23 before the market open, with the current consensus EPS estimate at $6.78. Because HCA reports before the open, the bulk of the options market's real expectation is embedded in the expiration cycle that settles the day of or immediately after the announcement rather than the next session. Traders watch implied volatility term structure for any bump in the 24-Oct or 31-Oct contracts compared with surrounding weeks; a higher implied move priced into those expirations reflects the premium buyers are paying for a binary event.
With the stock at $403.87, a 50-day exponential moving average of $399.31, and an RSI of 55.1, the current snapshot sits roughly in line with medium-term trend rather than at an extreme. That proximity to the 50-day EMA can compress the market's real expectation for the move if options participants believe the release is less likely to spark a trend break. Conversely, a pickup in call or put volume relative to open interest in the earliest weekly expirations would signal that directional players are building positions into the 2026-10-23 report.
What a Disciplined Trader Watches
A disciplined trader does not rely on the 100% beat rate as a predictive signal; the relevant question is whether the next report can beat and, more importantly, whether the market's real expectation has already been bought or sold ahead of time. Given the 1.75% average five-day drift, the historical tendency has been for the post-earnings move to extend modestly higher, but the 2026-01-27 quarter is a reminder that even a 7.4% positive surprise was met with a 2.89% next-day decline and a 1.31% five-day drop.
Practical markers include the $399.31 50-day EMA as a near-term reference level, the implied straddle price for the options expiring right after the 2026-10-23 release, and any deviation between the consensus $6.78 estimate and the unofficial consensus derived from options flow. With an RSI of 55.1, momentum is neither overbought nor oversold, so post-announcement continuation may depend more on whether management guidance confirms or resets the narrative than on the EPS print alone.
Frequently Asked Questions
What is HCA's earnings beat streak over the last eight quarters?
HCA has beaten consensus EPS estimates in each of the last eight reported quarters, resulting in an 8/8, or 100%, beat rate with an average earnings surprise of 6.4%.
How did HCA stock perform after the most recent earnings report on 2026-07-24?
After reporting actual EPS of $7.59 versus the $7.56 estimate on 2026-07-24, HCA stock rose 1.94% the next trading day and 5.34% over the following five trading days.
When is HCA's next earnings report and what is the consensus estimate?
HCA's next scheduled earnings report is 2026-10-23 before the market open, and the current consensus EPS estimate is $6.78.
For a deeper dive into how sell-side analysts, options positioning, and institutional flow are calibrated around the 2026-10-23 report, readers should consult the full institutional verdict on the platform.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-24 | $7.59 | $7.56 | +0.4% | +1.94% | +5.34% |
| 2026-04-24 | $7.15 | $7.12 | +0.4% | +3.09% | +0.15% |
| 2026-01-27 | $8.01 | $7.46 | +7.4% | -2.89% | -1.31% |
| 2025-10-24 | $6.96 | $5.79 | +20.2% | +4.66% | +2.83% |
| 2025-07-25 | $6.84 | $6.29 | +8.7% | - | - |
| 2025-04-25 | $6.45 | $5.75 | +12.2% | - | - |
Previous HCA editions
Get the institutional verdict on HCA
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the HCA verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.